The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and streamlined patient data, which currently suffers from inadequacies in comprehensiveness and accuracy. Addressing this pivotal issue carries immense benefits, particularly in the sphere of targeted trial recruitment efforts. By harnessing better patient data records, the possibilities
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
How to Achieve Health Equity in Decentralized Clinical Trials
Trial sponsors have made efforts to address underrepresentation and promote Diversity, Equity and Inclusion (DEI) in clinical trials since the Federal and Drug Administration’s (FDA) 2016 guidance, but a new report released by the Government Accountability Office (GAO) still shows a continuous presence of major gaps in patient diversity. It begs the question: how do we ultimately achieve full representation and ensure accountability to uphold the promises we have made for
Read More
Walgreens and Freenome Partner to Increase Diversity in Research
What You Should Know:
Walgreens and Freenome form a multi-year relationship to advance clinical studies of Freenome’s blood-based tests for the early detection of cancer. Walgreens will combine its national footprint, patient insights, compliant recruitment technology and local infrastructure to engage diverse patient populations in Freenome’s multi-cancer research program. Walgreens will initially recruit patients across diverse populations for Freenome’s Sanderson Study, which aims to
Read More
Navigating the Challenges of Biosample Consent in Clinical Trials
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including blood, tissue, saliva, hair, and other bodily fluids. The samples are then analyzed for their genetic, biochemical, or physiological properties, and the findings are used to further the understanding of human health, disease and the environment.
Many times, during clinical trials, sponsors will want to
Read More
Expectations For The Connected Care Business In The Years Ahead
Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover unknown yet valuable information. As unbelievable as it may seem, soothsayers peered into crystal balls aiming to help seekers look into the future for guidance, while prospectors would rely earnestly on divining rods as they attempted to locate underground riches of water or oil.
While
Read More
Sanofi & Flatiron Health Partner to Redesign Clinical Trial Experience for Sponsors
What You Should Know:
Flatiron Health announced a new partnership today with Sanofi in their pursuit to redesign the clinical trial experience for sponsors, sites, and patients in the therapeutic area of oncology. The multi-study partnership between Sanofi and Flatiron will focus on improving clinical trial data acquisition, delivery, and quality through site-facing technology that digitally transfers data captured in the electronic health record (EHR) directly into the electronic data
Read More
Notable Leverages GPT to Automate Patient Front Office Experience
What You Should Know:
Notable, an intelligent automation company for healthcare, launches Patient AI, a solution leveraging large language models (LLMs) and GPT (the technology powering ChatGPT) to bring personalization at scale to healthcare.Using GPT to scan existing clinical documentation, this tech can detect missed diagnoses, identify lapsed insurance cards, incorrect addresses, eligible clinical trials, or costly care gaps in real-time across an entire patient population.
How
Read More
Biostage Raises $6M to Advance Clinical Trials
What You Should Know:
Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock.The funds will be used to accelerate the clinical development of Biostage’s lead product candidate, the Biostage Esophageal Implant, or BEI. The FDA has approved a
Read More
Exec Hires: Clinical Trials Marketplace SubjectWell Appoints New CEO
What You Should Know:
- SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO.
- Fred will joins SubjectWell during a time of growth following the company’s Series B funding in November 2022, with the goal of accelerating technical solutions and building investor relations.
Fred Martin Bio
Fred brings more than 25 years of experience in
Read More
Patientory Launches Blockchain App Enabling Patients to Earn Money for Their Health Data
What You Should Know:
Patientory Inc., the creator of a blockchain-based, HIPAA-compliant, private medical data ecosystem, announced today that it has launched two solutions–Patientory Consumer Decentralized Application-designed to help patients more efficiently and securely store and earn money from their medical data and Neith Enterprise Dashboard in partnership with Prosper Healthtech, a community-backed organization committed to equity in Birmingham offering a supportive network of
Read More
